An observational study in Acute Dyspnea, sponsored by Central Hospital, Nancy, France. Status unknown at 9 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-10-10.
Sponsored by Central Hospital, Nancy, France · Observational
This is an observational prospective multicenter study of patients admitted for acute dyspnea in an emergency department of the participating centers in the Lorraine district.
The primary objective is to assess the outcome of this population according to the cause of acute dyspnea as well as identify the predictors of this outcome, both overall and according to each acute dyspnea cause.
This observational prospective multicenter study will be conducted using data from electronic medical records, acquired as part of usual care, in patients admitted for acute dyspnea in the emergency department. Clinical, treatment, laboratory and imaging data acquired during the hospitalization (in the emergency department and in the department that admitted the patients following the emergency department stay) will be collected.
Vital status will be recorded at 30 days and 1 year post-admission.
656 studies on the registry are indexed under Dyspnea; 153 are open to participants now.
This study's planned enrollment of 75,000 is above the median of 122 across 204 observational studies indexed under Dyspnea.
Browse Dyspnea studies →Central Hospital, Nancy, France is the lead sponsor of 778 studies on the registry; 183 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with acute dyspnea and treated in an emergency department of the participating centers in the Lorraine district.
Exclusion Criteria:
Patients admitted for acute dyspnea in the emergency department
All cause mortality
Time frame: From emergency admission for acute dyspnea up until 1 year
Demographic data
Time frame: through hospital stay, an average of 10 days
Clinical data
Time frame: through hospital stay, an average of 10 days
Treatment data
Time frame: through hospital stay, an average of 10 days
Laboratory data
Time frame: through hospital stay, an average of 10 days
Imaging data
Time frame: through hospital stay, an average of 10 days
Duration of hospitalization
including emergency stay and conventional hospitalization
Time frame: At final discharge, an average of 10 days after admission
Initial diagnosis in the emergency department
Time frame: At admission
Final diagnosis of the initial hospitalization stay
Time frame: At final discharge, an average of 10 days after admission
Brain Natriuretic Peptide
Time frame: Through hospital stay, an average of 10 days
Estimated glomerular function rate
Time frame: Through hospital stay, an average of 10 days
Estimated plasma volume
Time frame: Through hospital stay, an average of 10 days
Liver biological biomarkers
Time frame: Through hospital stay, an average of 10 days
Urea
Time frame: Through hospital stay, an average of 10 days
Use of non-invasive ventilation
Time frame: Through hospital stay, an average of 10 days
Time of use of non-invasive ventilation
Time frame: Through hospital stay, an average of 10 days
Use of diuretics
Time frame: Through hospital stay, an average of 10 days
Time of use of diuretics
Time frame: Through hospital stay, an average of 10 days
Use of nitrates
Time frame: Through hospital stay, an average of 10 days
Time of use of nitrates
Time frame: Through hospital stay, an average of 10 days
Department type admitting the patient following emergency management
intensive care unit, cardiology, cardiac intensive care unit, other ...
Time frame: Through hospital stay, an average of 10 days
All cause in-hospital mortality
Time frame: At final discharge, an average of 10 days after admission
Plan to share: No
This study is status unknown, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Central Hospital, Nancy, France